Article
VEGF-A-related genetic variants protect against Alzheimer's disease.
Aging - 28 Mar 2022
Petrelis Alexandros M, Stathopoulou Maria G, Kafyra Maria, Murray Helena, Masson Christine, Lamont John, Fitzgerald Peter, Dedoussis George, Yen Frances T, Visvikis-Siest Sophie
Abstract excerpt
The Apolipoprotein E (APOE) genotype has been shown to be the strongest genetic risk factor for Alzheimer's disease (AD). Moreover, both the lipolysis-stimulated lipoprotein receptor (LSR) and the vascular endothelial growth factor A (VEGF-A) are involved in the development of AD. The aim of the study was to develop a prediction model for AD including single nucleotide polymorphisms (SNP) of APOE, LSR and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
